Search research articles
Contact Us
Filters
Showing results (111-120 of 195) with videos related to
Page
of 20
Sort By:
Journal of Clinical & Experimental Immunology
|
June 1, 2026
Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury
Suresh B Rangasamy, Sumita Raha, Sridevi Dasarathi, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Improves Cognitive Functions in Mice after Controlled Cortical Impact Injury
Suresh B Rangasamy, Sumita Raha, Sridevi Dasarathy, et al.
The Journal of Biological Chemistry
|
March 23, 2006
Up-regulation of microglial CD11b expression by nitric oxide
Avik Roy, Yiu K Fung, Xiaojuan Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 28, 2017
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease
Goutam Chandra, Avik Roy, Suresh B Rangasamy, et al.
Frontiers in Cellular Neuroscience
|
June 5, 2024
Amelioration of experimental autoimmune encephalomyelitis by gemfibrozil in mice via PPARβ/δ: implications for multiple sclerosis
Susanta Mondal, Monica Sheinin, Suresh B Rangasamy, et al.
Science Signaling
|
November 29, 2018
Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells
Susanta Mondal, Malabendu Jana, Sridevi Dasarathi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 15, 2013
Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles
Saurabh Khasnavis, Avik Roy, Supurna Ghosh, et al.
Orphanet Journal of Rare Diseases
|
June 19, 2017
Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders
Kyeongsoon Kim, Hynda K Kleinman, Hahn-Jun Lee, et al.
The Journal of Biological Chemistry
|
September 20, 2012
Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy
Arunava Ghosh, Grant T Corbett, Frank J Gonzalez, et al.
Journal of Neurochemistry
|
February 16, 2017
Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis
Arunava Ghosh, Suresh Babu Rangasamy, Khushbu K Modi, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 195) with videos related to
Sort By:
Page
of 20
Journal of Clinical & Experimental Immunology
|
June 1, 2026
Corrected Version: Sodium Benzoate, A Metabolite of Cinnamon and A Food Additive, Improves Cognitive Functions in Mice After Controlled Cortical Impact Injury
Suresh B Rangasamy, Sumita Raha, Sridevi Dasarathi, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Improves Cognitive Functions in Mice after Controlled Cortical Impact Injury
Suresh B Rangasamy, Sumita Raha, Sridevi Dasarathy, et al.
The Journal of Biological Chemistry
|
March 23, 2006
Up-regulation of microglial CD11b expression by nitric oxide
Avik Roy, Yiu K Fung, Xiaojuan Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 28, 2017
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease
Goutam Chandra, Avik Roy, Suresh B Rangasamy, et al.
Frontiers in Cellular Neuroscience
|
June 5, 2024
Amelioration of experimental autoimmune encephalomyelitis by gemfibrozil in mice via PPARβ/δ: implications for multiple sclerosis
Susanta Mondal, Monica Sheinin, Suresh B Rangasamy, et al.
Science Signaling
|
November 29, 2018
Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells
Susanta Mondal, Malabendu Jana, Sridevi Dasarathi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 15, 2013
Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles
Saurabh Khasnavis, Avik Roy, Supurna Ghosh, et al.
Orphanet Journal of Rare Diseases
|
June 19, 2017
Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders
Kyeongsoon Kim, Hynda K Kleinman, Hahn-Jun Lee, et al.
The Journal of Biological Chemistry
|
September 20, 2012
Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy
Arunava Ghosh, Grant T Corbett, Frank J Gonzalez, et al.
Journal of Neurochemistry
|
February 16, 2017
Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis
Arunava Ghosh, Suresh Babu Rangasamy, Khushbu K Modi, et al.
Page
of 20